Raymond E. Weston

787 total citations
23 papers, 420 citations indexed

About

Raymond E. Weston is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Raymond E. Weston has authored 23 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Nephrology and 3 papers in Molecular Biology. Recurrent topics in Raymond E. Weston's work include Electrolyte and hormonal disorders (7 papers), Renal function and acid-base balance (6 papers) and Potassium and Related Disorders (3 papers). Raymond E. Weston is often cited by papers focused on Electrolyte and hormonal disorders (7 papers), Renal function and acid-base balance (6 papers) and Potassium and Related Disorders (3 papers). Raymond E. Weston collaborates with scholars based in United Kingdom, United States and Germany. Raymond E. Weston's co-authors include Jacob Grossman, Louis Leiter, Irwin B. Hanenson, Bernard Lown, Charles D. Enselberg, E.Raymond Borun, Doris J.W. Escher, L. Leiter, Bernard Sachs and Rachna Gupta and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Raymond E. Weston

22 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond E. Weston United Kingdom 13 136 107 82 69 52 23 420
P Cottier Switzerland 8 99 0.7× 96 0.9× 95 1.2× 52 0.8× 29 0.6× 39 335
Alan L. Orvis United States 13 127 0.9× 89 0.8× 46 0.6× 69 1.0× 107 2.1× 25 544
Glenn D. Lubash United States 11 89 0.7× 45 0.4× 87 1.1× 53 0.8× 36 0.7× 35 293
J Guédon France 8 75 0.6× 125 1.2× 96 1.2× 75 1.1× 40 0.8× 55 359
Kenneth H. Bleifer United States 9 197 1.4× 164 1.5× 54 0.7× 31 0.4× 126 2.4× 9 498
R R Ghose United Kingdom 9 71 0.5× 70 0.7× 130 1.6× 93 1.3× 69 1.3× 34 366
Cristobal G. Duarte United States 11 99 0.7× 214 2.0× 38 0.5× 91 1.3× 39 0.8× 19 460
M.L. Arce United States 4 104 0.8× 173 1.6× 38 0.5× 48 0.7× 146 2.8× 4 385
Morris Davidman United States 9 87 0.6× 165 1.5× 45 0.5× 55 0.8× 39 0.8× 13 369
John P. Peters United States 10 93 0.7× 81 0.8× 45 0.5× 74 1.1× 97 1.9× 22 571

Countries citing papers authored by Raymond E. Weston

Since Specialization
Citations

This map shows the geographic impact of Raymond E. Weston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond E. Weston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond E. Weston more than expected).

Fields of papers citing papers by Raymond E. Weston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond E. Weston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond E. Weston. The network helps show where Raymond E. Weston may publish in the future.

Co-authorship network of co-authors of Raymond E. Weston

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond E. Weston. A scholar is included among the top collaborators of Raymond E. Weston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond E. Weston. Raymond E. Weston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Richard, G. H. Beastall, Esther M. Brown, et al.. (1989). How sensitive are immunometric assays for thyrotropin?. Clinical Chemistry. 35(2). 289–291. 26 indexed citations
2.
Weston, Raymond E.. (1965). Clinical Use of Stylet-Catheter For Peritoneal Dialysis. Archives of Internal Medicine. 115(6). 659–659. 31 indexed citations
3.
Grossman, Jay, et al.. (1959). Measurement of inferior vena caval blood flow in man. Journal of Applied Physiology. 14(6). 951–955. 5 indexed citations
4.
Sachs, Bernard, et al.. (1958). EFFECT OF TRIIODOTHYRONINE ON THE SERUM LIPIDS AND LIPOPROTEINS OF EUTHYROID AND HYPERTHYROID SUBJECTS*. The Journal of Clinical Endocrinology & Metabolism. 18(5). 506–515. 9 indexed citations
5.
Weston, Raymond E.. (1957). THE MODE AND MECHANISM OF MERCURIAL DIURESIS IN NORMAL SUBJECTS AND EDEMATOUS CARDIAC PATIENTS. Annals of the New York Academy of Sciences. 65(5). 576–600. 16 indexed citations
6.
Sachs, Bernard, et al.. (1956). EFFECTS OF THE SYNTHETIC ANABOLIC STEROID, 17-ETHYL-19-NORTESTOSTERONE, ON SERUM PROTEINS, LIPOPROTEINS AND LIPIDS IN HUMAN SUBJECTS*. The Journal of Clinical Endocrinology & Metabolism. 16(10). 1388–1391. 12 indexed citations
7.
Hanenson, Irwin B., Bernard Goluboff, Jacob Grossman, Raymond E. Weston, & Louis Leiter. (1956). Studies on Water Excretion Following Intravenous Hydration and the Administration of Pitressin or Nicotine in Congestive Heart Failure. Circulation. 13(2). 242–251. 20 indexed citations
8.
Weston, Raymond E., et al.. (1956). DECREASED ANTIDIURETIC RESPONSE TO BETA-HYPOPHAMINE IN HYPERTHYROIDISM*. The Journal of Clinical Endocrinology & Metabolism. 16(3). 322–337. 8 indexed citations
9.
Weston, Raymond E.. (1955). Fluids and Electrolytes. Medical Clinics of North America. 39(3). 623–642.
10.
Grossman, Jacob, Raymond E. Weston, E.Raymond Borun, & Louis Leiter. (1955). FACTORS INFLUENCING THE COURSE OF MERCURIAL DIURESIS DURING PITRESSIN® INFUSION IN NORMAL SUBJECTS 12. Journal of Clinical Investigation. 34(11). 1611–1624. 13 indexed citations
11.
Leiter, Louis, Raymond E. Weston, & Jacob Grossman. (1953). The low sodium syndrome: its origins and varieties.. PubMed. 29(11). 833–45. 12 indexed citations
12.
Grossman, Jacob, et al.. (1953). Studies on intravenous water diuresis and nicotine and pitressin antidiuresis in patients with liver disease. The American Journal of Medicine. 14(4). 494–495. 1 indexed citations
13.
Grossman, Jacob, Raymond E. Weston, Louis Leiter, et al.. (1953). A METHOD FOR DETERMINING CARDIAC OUTPUT BY THE DIRECT FICK PRINCIPLE WITHOUT GAS ANALYSIS 12. Journal of Clinical Investigation. 32(2). 161–171. 2 indexed citations
14.
Hanenson, Irwin B., Raymond E. Weston, Jacob Grossman, & Louis Leiter. (1953). Pathogenesis and Treatment of Congestive Heart Failure. Medical Clinics of North America. 37(3). 643–658. 7 indexed citations
15.
Weston, Raymond E., et al.. (1953). STUDIES ON INTRAVENOUS WATER DIURESIS AND NICOTINE AND PITRESSIN ANTIDURESIS IN NORMAL SUBJECTS AND PATIENTS WITH LIVER DISEASE 1. Journal of Clinical Investigation. 32(5). 422–427. 24 indexed citations
16.
Weston, Raymond E., et al.. (1953). Metabolic studies on the effects of ion exchange resins in edematous patients with cardiac and renal disease. The American Journal of Medicine. 14(4). 404–424. 18 indexed citations
17.
Weston, Raymond E., Jacob Grossman, & Louis Leiter. (1951). THE EFFECT OF MERCURIAL DIURETICS ON RENAL AMMONIA AND TITRATABLE ACIDITY PRODUCTION IN ACIDOTIC HUMAN SUBJECTS WITH REFERENCE TO SITE OF DIURETIC ACTION 1. Journal of Clinical Investigation. 30(11). 1262–1271. 14 indexed citations
18.
Lown, Bernard, et al.. (1951). Interrelation between Potassium Metabolism and Digitalis Toxicity in Heart Failure.. Experimental Biology and Medicine. 76(4). 797–801. 62 indexed citations
19.
Grossman, Jacob, et al.. (1951). URINARY AND FECAL EXCRETION OF MERCURY IN MAN FOLLOWING ADMINISTRATION OF MERCURIAL DIURETICS 1. Journal of Clinical Investigation. 30(11). 1208–1220. 22 indexed citations
20.
Weston, Raymond E., et al.. (1951). RENAL EXTRACTION AND EXCRETION OF MERCURY IN MAN FOLLOWING INTRAVENOUSLY ADMINISTERED MERCURIAL DIURETICS 1. Journal of Clinical Investigation. 30(11). 1221–1227. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Cottier Breakdown of academic impact, for papers by Alan L. Orvis Breakdown of academic impact, for papers by Glenn D. Lubash Breakdown of academic impact, for papers by J Guédon Breakdown of academic impact, for papers by Kenneth H. Bleifer Breakdown of academic impact, for papers by R R Ghose Breakdown of academic impact, for papers by Cristobal G. Duarte Breakdown of academic impact, for papers by M.L. Arce Breakdown of academic impact, for papers by Morris Davidman Breakdown of academic impact, for papers by John P. Peters
Rankless by CCL
2026